Dear Partners,   

The European Union, through their programme Horizon Europe, has published a call for proposal for the development of novel vaccines for viral pathogens with epidemic potential

This topic aims to support activities that contribute to the EU’s strategic objective of "tackling diseases and reducing the overall disease burden". Proposals should deliver results that meet all the following expected outcomes :

  • The scientific and clinical communities have a better understanding of and access to experimental vaccines for the prevention and treatment of emerging or re-emerging viral infections, as well as for further clinical investigation, including better understanding of biological sex and social determinants that influence immune response, vaccine efficacy, safety, and uptake.
  • Candidate vaccines are available for emerging and re-emerging viral infections, increasing therapeutic options for clinical deployment in case of an epidemic or pandemic.

 

The proposed work should aim to advance the development of existing prophylactic and therapeutic vaccine candidates targeting exclusiverly one of the following viruses :

Junin mammarenavirus

Lassa mammarenavirus

Andes virus,

Hantaan virus

Sin Nombre virus

Hendra virus

Enterovirus D68

Venezuelan equine encephalitis virus. 

 

Why is this relevant for you ?  Med initiative III

Lebanese universities are eligible to participate as partners to Horizon Europe under Pillar II – Global Challenges & European Industrial Competitiveness. This pillar promotes international collaboration to address major societal challenges while strengthening Europe’s innovation capacity.

Within this framework, Lebanese institutions can collaborate with European research and innovation actors across the following thematic clusters: Health ; Culture, Creativity & Inclusive Society ; Civil Security for Society ; Digital, Industry & Space ; Climate, Energy & Mobility ; Food, Bioeconomy, Natural Resources, Agriculture & Environment

The European Union explicitly encourages strengthened cooperation with Mediterranean partner countries for this call. In such cases, Lebanese universities represent a strategic added value within a consortium.

For more information, you may consult the documents below “Horizon Europe for Lebanese universities” and “factsheet on mediterrenean initiative III”

 

Reference : 

HORIZON‑HLTH‑2026‑01‑DISEASE‑04 — Development of novel vaccines for viral pathogens with epidemic potential

 

0
0
0
Save
Share
contact-details
no email, please refer to the webpage
no@no.com
Start date: Feb 10, 2026
End date: Apr 16, 2026
MORE DETAILS
Funding AmountUp to 9M-11M€
Related Documents